Trial Number
478-24
Participant Age Range
50 years and older
Participant Gender
Any
Enrolling Participants
Yes
Overview
“Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare study)”
This multi-center comparative prospective cohort study is designed to understand the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection test (MCED). The study will compare Medicare beneficiaries (aged ≥50 years) who have received the Galleri test plus usual care (Galleri + UC), with Medicare beneficiaries who receive usual care (UC) alone.